A randomized controlled study of acupuncture in the treatment of diarrhea-predominant irritable bowel syndrome
- Conditions
- irritable bowel syndrome
- Registration Number
- ITMCTR2200006702
- Lead Sponsor
- Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Persons aged 18-70 years old, regardless of gender;
(2) Those who meet the above diagnostic criteria of IBS-D Rome IV; have typical symptoms of IBS-D;
(3) The course of the disease exceeds 6 months;
(4) The total score of the IBS Severity Scale at the baseline period is =75 points;
(5) Patients with mild or moderate depression or anxiety, that is, those with a GAD-7 total score of 5-15, or a PHQ-9 total score of 5-15;
(6) Normal cognitive function, good compliance, willing to cooperate with the research, voluntarily participate in this trial and sign the informed consent.
Note: Inclusion only if all the above conditions are met.
(1) Those who meet the diagnostic criteria of IBS-C, IBS-M, and IBS-U Rome IV;
(2) Those who have been diagnosed with organic diseases of the digestive system in the past, such as inflammatory bowel disease, intestinal tuberculosis, intestinal tumors, etc.;
(3) Patients with severe heart, cerebrovascular system, liver, kidney, hematopoietic system, endocrine system, and rheumatic immune system in the past;
(4) Severe mental illness and obvious cognitive impairment in the past;
(5) Patients who have received acupuncture treatment in the past three months;
(6) Pregnant or lactating women;
(7) Patients who are participating in other clinical studies.
Note: All patients who meet any one of the above items will be excluded.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VSI;GAD-7;PHQ-9;IBS-QOL;PQSI;EEG;IBS-SSS;
- Secondary Outcome Measures
Name Time Method